An Open-label Pilot Study of Purified Tea-derived Epicatechin to Improve Mitochondrial Function, Strength and Skeletal Muscle Exercise Response in Becker Muscular Dystrophy.
Phase of Trial: Phase I/II
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Epicatechin (Primary)
- Indications Muscular dystrophies
- Focus Therapeutic Use
- 10 Mar 2017 Planned End Date changed from 1 May 2014 to 1 Jul 2018.
- 10 Mar 2017 Planned primary completion date changed from 1 May 2014 to 1 Jan 2018.
- 10 Feb 2016 New trial record